COVID-19 (omicron JN.1) vaccine is under clinical development by Moderna and currently in Pre-Registration for Coronavirus Disease 2019 (COVID-19).

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

MRNA-1273.213 is under clinical development by Moderna and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

Five years after the virus that causes COVID emerged in China it still holds some mysteries. The disease has killed an ...